NOVEL OMEZA® OCM™ WOUND HEALING PLATFORM COMBINED WITH OFFLOADING IN PATIENTS WITH DIABETIC FOOT ULCERS DEMONSTRATED DRAMATIC HEALING RATES WITHIN 12 WEEKS OR LESS
"We're extremely encouraged by the final results of our clinical trial evaluating Omeza®'s OCM™ platform, which showed significant healing—and in over half the cases, complete closure—of patients' diabetic wounds in twelve weeks or less.
- "We're extremely encouraged by the final results of our clinical trial evaluating Omeza®'s OCM™ platform, which showed significant healing—and in over half the cases, complete closure—of patients' diabetic wounds in twelve weeks or less.
- Patients also reduced or eliminated weight bearing on the affected foot, known as offloading, to support healing.
- A control group received current standards of wound care, including offloading, debridement, collagen, hypochlorite solution, and/or wound dressings containing silver alginate.
- Five patients had DFUs that were greater than 12 months old, and 3 of those patients had 100% PAR.